375 related articles for article (PubMed ID: 7568029)
1. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
Li R; Bianchet MA; Talalay P; Amzel LM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
Cavelier G; Amzel LM
Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
[TBL] [Abstract][Full Text] [Related]
3. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
Zhao Q; Yang XL; Holtzclaw WD; Talalay P
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
[TBL] [Abstract][Full Text] [Related]
4. Structure, biochemical and kinetic properties of recombinant Pst2p from Saccharomyces cerevisiae, a FMN-dependent NAD(P)H:quinone oxidoreductase.
Koch K; Hromic A; Sorokina M; Strandback E; Reisinger M; Gruber K; Macheroux P
Biochim Biophys Acta Proteins Proteom; 2017 Aug; 1865(8):1046-1056. PubMed ID: 28499769
[TBL] [Abstract][Full Text] [Related]
5. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
[TBL] [Abstract][Full Text] [Related]
6. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.
Chen S; Deng PS; Bailey JM; Swiderek KM
Protein Sci; 1994 Jan; 3(1):51-7. PubMed ID: 7511454
[TBL] [Abstract][Full Text] [Related]
7. Two-electron reduction of quinones by rat liver NAD(P)H:quinone oxidoreductase: quantitative structure-activity relationships.
Anusevicius Z; Sarlauskas J; Cenas N
Arch Biochem Biophys; 2002 Aug; 404(2):254-62. PubMed ID: 12147263
[TBL] [Abstract][Full Text] [Related]
8. Structure, function, and mechanism of cytosolic quinone reductases.
Bianchet MA; Erdemli SB; Amzel LM
Vitam Horm; 2008; 78():63-84. PubMed ID: 18374190
[TBL] [Abstract][Full Text] [Related]
9. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
[TBL] [Abstract][Full Text] [Related]
11. Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: identification of a new and potent inhibitor.
Prochaska HJ
Arch Biochem Biophys; 1988 Dec; 267(2):529-38. PubMed ID: 3214167
[TBL] [Abstract][Full Text] [Related]
12. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
13. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
Fisher GR; Gutierrez PL
Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
[TBL] [Abstract][Full Text] [Related]
14. Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.
Horie S
Kitasato Arch Exp Med; 1990 Apr; 63(1):11-30. PubMed ID: 2125671
[TBL] [Abstract][Full Text] [Related]
15. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
16. The structural and functional basis of catalysis mediated by NAD(P)H:acceptor Oxidoreductase (FerB) of Paracoccus denitrificans.
Sedláček V; Klumpler T; Marek J; Kučera I
PLoS One; 2014; 9(5):e96262. PubMed ID: 24817153
[TBL] [Abstract][Full Text] [Related]
17. A Bacterial Multidomain NAD-Independent d-Lactate Dehydrogenase Utilizes Flavin Adenine Dinucleotide and Fe-S Clusters as Cofactors and Quinone as an Electron Acceptor for d-Lactate Oxidization.
Jiang T; Guo X; Yan J; Zhang Y; Wang Y; Zhang M; Sheng B; Ma C; Xu P; Gao C
J Bacteriol; 2017 Nov; 199(22):. PubMed ID: 28847921
[TBL] [Abstract][Full Text] [Related]
18. DT-diaphorase. Redox potential, steady-state, and rapid reaction studies.
Tedeschi G; Chen S; Massey V
J Biol Chem; 1995 Jan; 270(3):1198-204. PubMed ID: 7836380
[TBL] [Abstract][Full Text] [Related]
19. Structure and mechanism of cytosolic quinone reductases.
Bianchet MA; Foster C; Faig M; Talalay P; Amzel LM
Biochem Soc Trans; 1999 Aug; 27(4):610-5. PubMed ID: 10917652
[No Abstract] [Full Text] [Related]
20. High-resolution studies of hydride transfer in the ferredoxin:NADP
Kean KM; Carpenter RA; Pandini V; Zanetti G; Hall AR; Faber R; Aliverti A; Karplus PA
FEBS J; 2017 Oct; 284(19):3302-3319. PubMed ID: 28783258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
